Age and Sex Distributions of MOG-IgG and AQP4-IgG Positive Sera from a Large Neuroimmunology Laboratory Database

被引:0
|
作者
Vorasoot, Nisa [1 ]
Kunchok, Amy [4 ]
Edmond, Matthew C. [2 ]
McCombe, Jennifer [5 ]
Redenbaugh, Vyanka [1 ]
Cacciaguerra, Laura [1 ]
Thakolwiboon, Smathorn [1 ]
Tisavipat, Nanthaya [1 ]
Abdulrahman, Yahya [1 ]
Chen, John [3 ]
Pittock, Sean
Flanagan, Eoin [1 ]
机构
[1] Mayo Clin, Neurol, Rochester, MN USA
[2] Mayo Clin, Lab Med & Pathol, Rochester, MN USA
[3] Mayo Clin, Ophthalmol, Rochester, MN USA
[4] Cleveland Clin, Neurol Inst, Mellen Ctr, Neurol, Cleveland, OH USA
[5] Univ Alberta, Dept Med, Div Neurol, Edmonton, AB, Canada
关键词
D O I
10.1212/WNL.0000000000204098
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P2-5.028
引用
收藏
页数:4
相关论文
共 50 条
  • [1] Spinal cord lesions and atrophy in NMOSD with AQP4-IgG and MOG-IgG associated autoimmunity
    Chien, Claudia
    Scheel, Michael
    Schmitz-Huebsch, Tanja
    Borisow, Nadja
    Ruprecht, Klemens
    Bellmann-Strobl, Judith
    Paul, Friedemann
    Brandt, Alexander U.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (14) : 1926 - 1936
  • [2] Brain MRI abnormalities in MOG-IgG and AQP4-IgG seropositive neuromyelitis optica spectrum disorder
    Schmidt, F.
    Borisow, N.
    Ruprecht, K.
    Bellmann-Strobl, J.
    Brandt, A.
    Paul, F.
    Scheel, M.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 636 - 636
  • [3] Longitudinal Evaluation of Serum MOG-IgG and AQP4-IgG Antibodies in NMOSD by a Semiquantitative Ratiometric Method
    Bollo, Luca
    Iaffaldano, Pietro
    Ruggieri, Maddalena
    Palazzo, Claudia
    Mastrapasqua, Mariangela
    Manni, Alessia
    Paolicelli, Damiano
    Frigeri, Antonio
    Trojano, Maria
    [J]. FRONTIERS IN NEUROLOGY, 2021, 12
  • [4] HLA association in MOG-IgG and AQP4-IgG related inflammatory diseases of the CNS in the Dutch Caucasian population
    Bruijstens, A. L.
    Wong, Y. Y. M.
    van Pelt, E. D.
    van der Linden, P. J. E.
    Haasnoot, G. W.
    Neuteboom, R. F.
    Claas, F. H. J.
    Hintzen, R. Q.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 141 - 141
  • [5] Effectiveness of mycophenolate mofetil as first line therapy in AQP4-IgG, MOG-IgG and seronegative neuromyelitis optica spectrum disorders
    Montcuquet, A.
    Collongues, N.
    Papeix, C.
    Zephir, H.
    Audoin, B.
    Laplaud, D.
    Bourre, B.
    Brochet, B.
    Camdessanche, J-P
    Labauge, P.
    Moreau, T.
    Stankoff, B.
    De Seze, J.
    Vukusic, S.
    Marignier, R.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 282 - 283
  • [6] Clinical predictive factors for diagnosis of MOG-IgG and AQP4-IgG related paediatric optic neuritis: a Chinese cohort study
    Yang, Mo
    Wu, Yiqun
    Lai, Mengying
    Song, Honglu
    Li, Hongen
    Sun, Mingming
    Xie, Lindan
    Zhou, Huanfen
    Xu, Quangang
    Wei, Shihui
    Wu, Weiping
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2022, 106 (02) : 262 - 266
  • [7] Distinction of double seronegative neuromyelitis optica spectrum disease from AQP4-IgG seropositive and MOG-IgG seropositive cases in Asian patients
    Kim, H. W.
    Lee, E. J.
    Lee, S.
    Kim, H.
    Kim, S. K.
    Kim, S.
    Choi, L.
    Lim, Y. M.
    Kim, K. K.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 587 - 587
  • [8] Retinal Nerve Fiber Layer May Be Better Preserved in MOG-IgG versus AQP4-IgG Optic Neuritis: A Cohort Study
    Stiebel-Kalish, Hadas
    Lotan, Itay
    Brody, Judith
    Chodick, Gabriel
    Bialer, Omer
    Marignier, Romain
    Bach, Michael
    Hellmann, Mark Andrew
    [J]. PLOS ONE, 2017, 12 (01):
  • [9] Neuromyelitis optica spectrum disorders: comparison of clinical and MRI characteristics of AQP4-IgG versus MOG-IgG seropositive cases in the Netherlands
    van Pelt, E. D.
    Wong, Y. Y.
    Ketelslegers, I. A.
    Hamann, D.
    Hintzen, R. Q.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 372 - 372
  • [10] Anti-aquaporin-4 antibody (AQP4-IgG) and anti-myelin oligodendrocyte glycoprotein antibody (MOG-IgG) in the cerebrospinal fluid
    Akaishi, Tetsuya
    Misu, Tatsuro
    [J]. NEURAL REGENERATION RESEARCH, 2024, 19 (05) : 949 - 950